Jiangxi University of Traditional Chinese Medicine.
Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Medicine (Baltimore). 2021 Mar 19;100(11):e24935. doi: 10.1097/MD.0000000000024935.
As a common respiratory disease, Chronic Obstructive Pulmonary Disease (COPD) develops progressively. Du moxibustion can effectively treat COPD, and no adverse reactions have been reported. This research mainly evaluated the efficacy and safety of Du moxibustion in the treatment of COPD.
Seven databases (PubMed, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literatures Database (CBM), Wanfang Database (WF), Chinese Scientific Journal Database (VIP)) will be searched for all relevant eligible randomized controlled trials (RCTs) from the date of establishment to January 6, 2021. No matter whether they were blind or not, and regardless of the language and type of publication, these experiments could be included. Two authors (YRZ, ARG) will search the database respectively, extract relevant data, and use the Cochrane bias risk tool to evaluate the quality of the literature. RevMan V5.3 software will be used for data processing.
The results of this research are mainly used to evaluate the efficacy and safety of Du moxibustion in the treatment of COPD.
This systematical review is expected to provide evidence-based and valuable suggestions for Du moxibustion in the treatment of COPD.
INPLASY202110045.
作为一种常见的呼吸系统疾病，慢性阻塞性肺疾病（COPD）呈进行性发展。艾灸能有效治疗 COPD，且未报道不良反应。本研究主要评估艾灸治疗 COPD 的疗效和安全性。
检索 7 个数据库（PubMed、Cochrane Library、Embase、中国知网（CNKI）、中国生物医学文献数据库（CBM）、万方数据库（WF）、中文科技期刊数据库（VIP）），全面收集艾灸治疗 COPD 的随机对照试验（RCT），检索时限自建库至 2021 年 1 月 6 日。无论是否采用盲法，无论语言和出版类型，均纳入研究。由 2 位作者（YRZ、ARG）独立筛选文献、提取资料并采用 Cochrane 偏倚风险工具评价文献质量，RevMan V5.3 软件进行数据处理。
本研究的结果主要用于评价艾灸治疗 COPD 的疗效和安全性。
本系统评价有望为艾灸治疗 COPD 提供基于证据的、有价值的建议。
INPLASY202110045。
